435 related articles for article (PubMed ID: 25875424)
1. A glycolytic phenotype is associated with prostate cancer progression and aggressiveness: a role for monocarboxylate transporters as metabolic targets for therapy.
Pertega-Gomes N; Felisbino S; Massie CE; Vizcaino JR; Coelho R; Sandi C; Simoes-Sousa S; Jurmeister S; Ramos-Montoya A; Asim M; Tran M; Oliveira E; Lobo da Cunha A; Maximo V; Baltazar F; Neal DE; Fryer LG
J Pathol; 2015 Aug; 236(4):517-30. PubMed ID: 25875424
[TBL] [Abstract][Full Text] [Related]
2. Targeting lactate production and efflux in prostate cancer.
Pereira-Nunes A; Simões-Sousa S; Pinheiro C; Miranda-Gonçalves V; Granja S; Baltazar F
Biochim Biophys Acta Mol Basis Dis; 2020 Nov; 1866(11):165894. PubMed ID: 32650130
[TBL] [Abstract][Full Text] [Related]
3. Monocarboxylate transport inhibition potentiates the cytotoxic effect of 5-fluorouracil in colorectal cancer cells.
Amorim R; Pinheiro C; Miranda-Gonçalves V; Pereira H; Moyer MP; Preto A; Baltazar F
Cancer Lett; 2015 Aug; 365(1):68-78. PubMed ID: 26021766
[TBL] [Abstract][Full Text] [Related]
4. Lactate transporters in the context of prostate cancer metabolism: what do we know?
Pértega-Gomes N; Baltazar F
Int J Mol Sci; 2014 Oct; 15(10):18333-48. PubMed ID: 25314297
[TBL] [Abstract][Full Text] [Related]
5. Tumor-stroma metabolic relationship based on lactate shuttle can sustain prostate cancer progression.
Sanità P; Capulli M; Teti A; Galatioto GP; Vicentini C; Chiarugi P; Bologna M; Angelucci A
BMC Cancer; 2014 Mar; 14():154. PubMed ID: 24597899
[TBL] [Abstract][Full Text] [Related]
6. Androgens enhance the glycolytic metabolism and lactate export in prostate cancer cells by modulating the expression of GLUT1, GLUT3, PFK, LDH and MCT4 genes.
Vaz CV; Marques R; Alves MG; Oliveira PF; Cavaco JE; Maia CJ; Socorro S
J Cancer Res Clin Oncol; 2016 Jan; 142(1):5-16. PubMed ID: 26048031
[TBL] [Abstract][Full Text] [Related]
7. Androgen-responsive and nonresponsive prostate cancer cells present a distinct glycolytic metabolism profile.
Vaz CV; Alves MG; Marques R; Moreira PI; Oliveira PF; Maia CJ; Socorro S
Int J Biochem Cell Biol; 2012 Nov; 44(11):2077-84. PubMed ID: 22964025
[TBL] [Abstract][Full Text] [Related]
8. Reciprocal metabolic reprogramming through lactate shuttle coordinately influences tumor-stroma interplay.
Fiaschi T; Marini A; Giannoni E; Taddei ML; Gandellini P; De Donatis A; Lanciotti M; Serni S; Cirri P; Chiarugi P
Cancer Res; 2012 Oct; 72(19):5130-40. PubMed ID: 22850421
[TBL] [Abstract][Full Text] [Related]
9. MCT4 as a potential therapeutic target for metastatic gastric cancer with peritoneal carcinomatosis.
Lee JY; Lee I; Chang WJ; Ahn SM; Lim SH; Kim HS; Yoo KH; Jung KS; Song HN; Cho JH; Kim SY; Kim KM; Lee S; Kim ST; Park SH; Lee J; Park JO; Park YS; Lim HY; Kang WK
Oncotarget; 2016 Jul; 7(28):43492-43503. PubMed ID: 27224918
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia, cancer metabolism and the therapeutic benefit of targeting lactate/H(+) symporters.
Marchiq I; Pouysségur J
J Mol Med (Berl); 2016 Feb; 94(2):155-71. PubMed ID: 26099350
[TBL] [Abstract][Full Text] [Related]
11. Targeting lactate transport suppresses in vivo breast tumour growth.
Morais-Santos F; Granja S; Miranda-Gonçalves V; Moreira AH; Queirós S; Vilaça JL; Schmitt FC; Longatto-Filho A; Paredes J; Baltazar F; Pinheiro C
Oncotarget; 2015 Aug; 6(22):19177-89. PubMed ID: 26203664
[TBL] [Abstract][Full Text] [Related]
12. Disruption of BASIGIN decreases lactic acid export and sensitizes non-small cell lung cancer to biguanides independently of the LKB1 status.
Granja S; Marchiq I; Le Floch R; Moura CS; Baltazar F; Pouysségur J
Oncotarget; 2015 Mar; 6(9):6708-21. PubMed ID: 25894929
[TBL] [Abstract][Full Text] [Related]
13. Monocarboxylate transporters as targets and mediators in cancer therapy response.
Baltazar F; Pinheiro C; Morais-Santos F; Azevedo-Silva J; Queirós O; Preto A; Casal M
Histol Histopathol; 2014 Dec; 29(12):1511-24. PubMed ID: 24921258
[TBL] [Abstract][Full Text] [Related]
14. Role of monocarboxylate transporters in human cancers: state of the art.
Pinheiro C; Longatto-Filho A; Azevedo-Silva J; Casal M; Schmitt FC; Baltazar F
J Bioenerg Biomembr; 2012 Feb; 44(1):127-39. PubMed ID: 22407107
[TBL] [Abstract][Full Text] [Related]
15. Exercise-induced changes in tumour LDH-B and MCT1 expression are modulated by oestrogen-related receptor alpha in breast cancer-bearing BALB/c mice.
Aveseh M; Nikooie R; Aminaie M
J Physiol; 2015 Jun; 593(12):2635-48. PubMed ID: 25907793
[TBL] [Abstract][Full Text] [Related]
16. Role of monocarboxylate transporters and glucose transporters in prostate cancer.
Vovdenko S; Morozov A; Ali S; Kogan E; Bezrukov E
Urologia; 2023 Aug; 90(3):491-498. PubMed ID: 35903832
[TBL] [Abstract][Full Text] [Related]
17. Enhancing the anticancer effect of androgen deprivation therapy by monocarboxylate transporter 1 inhibitor in prostate cancer cells.
Kim J; Park S; Kim S; Ryu S; Hwang H; Cho S; Han Y; Kim J; Park Y; Lee EK; Lee M
Prostate; 2024 Jun; 84(9):814-822. PubMed ID: 38558458
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia-mediated upregulation of MCT1 expression supports the glycolytic phenotype of glioblastomas.
Miranda-Gonçalves V; Granja S; Martinho O; Honavar M; Pojo M; Costa BM; Pires MM; Pinheiro C; Cordeiro M; Bebiano G; Costa P; Reis RM; Baltazar F
Oncotarget; 2016 Jul; 7(29):46335-46353. PubMed ID: 27331625
[TBL] [Abstract][Full Text] [Related]
19. A Holistic Evolutionary and 3D Pharmacophore Modelling Study Provides Insights into the Metabolism, Function, and Substrate Selectivity of the Human Monocarboxylate Transporter 4 (hMCT4).
Papakonstantinou E; Vlachakis D; Thireou T; Vlachoyiannopoulos PG; Eliopoulos E
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805725
[TBL] [Abstract][Full Text] [Related]
20. Monocarboxylate transporters in cancer.
Payen VL; Mina E; Van Hée VF; Porporato PE; Sonveaux P
Mol Metab; 2020 Mar; 33():48-66. PubMed ID: 31395464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
